tiprankstipranks

Ronald Barrett Insider Profile

4 Followers
Ronald Barrett, Director at Janux Therapeutics Inc, holds 11.75K shares in Janux Therapeutics Inc (Ticker: JANX), holds 5.13K shares in Concert Pharma (Ticker: CNCE), holds 359.94K shares in XenoPort (Ticker: XNPT).
tipranks
Ronald Barrett

Ronald Barrett
Janux Therapeutics Inc (JANX)
Director

Ranked #16,316 out of 108,921 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+59.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$208K
100.00%
A breakdown of Ronald Barrett's holdings

Insider Roles

Janux Therapeutics Inc
(JANX)
Director
Roles that Ronald Barrett holds in companies

Most Profitable Insider Trade

Stock:
XenoPort
(XNPT)
Rating:Informative Buy
Date:May 28, 2014 - May 28, 2015
Return:+93.20%
The most profitable trade made by Ronald Barrett

Ronald Barrett's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Janux Therapeutics Inc
Jun 12, 2026
Director
Uninformative Buy
$207.74K
XNPT
XenoPort
Sep 02, 2015
Uninformative Sell
87.50K
$2.54M
CNCE
Concert Pharma
Jun 11, 2021
Uninformative Buy
$42.90K
List of latest transactions for each holding click on a transaction to see Ronald Barrett's performance on stock

Ronald Barrett insider profile FAQ

What is the percentage of profitable transactions made by Ronald Barrett?
The percentage of profitable transactions made by Ronald Barrett is 100%.
    What is the average return per transaction made by Ronald Barrett?
    The average return per transaction made by Ronald Barrett is 59.70%.
      What stocks does Ronald Barrett hold?
      Ronald Barrett holds: JANX, XNPT, CNCE stocks.
        What was Ronald Barrett’s latest transaction?
        Ronald Barrett latest transaction was an Uninformative Buy of ―.
          What was Ronald Barrett's most profitable transaction?
          Ronald Barrett’s most profitable transaction was an Informative Buy of XNPT stock on May 28, 2014. The return on the trade was 93.20%.
            What is Ronald Barrett's role in Janux Therapeutics Inc?
            Ronald Barrett's role in Janux Therapeutics Inc is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.